MIRA insider transactions
MIRA Pharmaceuticals Inc. (MIRA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for MIRA
- SEC Form 3 filed by new insider Mushak Andriy3 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- SEC Form 4 filed by Aminov Erez4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- Aminov Erez was granted 125,000 shares, exercised 613,595 shares at a strike of $0.96 and sold $1,294,685 worth of shares (613,595 units at $2.11), increasing direct ownership by 4% to 3,592,666 units (SEC Form 5)5 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- Director Shekhat Denil Nanji was granted 22,378 shares (SEC Form 4)4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- Chief Executive Officer Aminov Erez was granted 2,685,456 shares, increasing direct ownership by 318% to 3,530,156 units (SEC Form 4)4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Aminov Erez4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- Chief Executive Officer Aminov Erez was granted 62,500 shares, increasing direct ownership by 8% to 844,700 units (SEC Form 4)4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- SEC Form 3 filed by new insider Weichselbaum Alan3 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- SEC Form 4 filed by Director Macpherson Edward Clouston4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- SEC Form 4 filed by Director Del Giudice Matthew Paul4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Yanez Michelle4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Aminov Erez4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- SEC Form 4 filed by Director Shekhat Denil Nanji4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- SEC Form 4 filed by Director Whalen Matthew Pratt4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- Chief Executive Officer Aminov Erez sold $133,649 worth of shares (100,000 units at $1.34), decreasing direct ownership by 9% to 1,061,200 units (SEC Form 4)4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- SEC Form 3 filed by new insider Whalen Matthew Pratt3 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- Large owner Mcnulty Brian Patrick sold $392,000 worth of shares (200,000 units at $1.96) (SEC Form 4)4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- SEC Form 4 filed by Director Shekhat Denil Nanji4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- SEC Form 4 filed by Aminov Erez4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- Aminov Erez bought $8,176 worth of shares (8,700 units at $0.94) (SEC Form 4)4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- SEC Form 4 filed by Aminov Erez4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- SEC Form 4 filed by Shekhat Denil Nanji4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- SEC Form 4 filed by Yanez Michelle4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- SEC Form 4 filed by Del Giudice Matthew Paul4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- SEC Form 4 filed by Macpherson Edward Clouston4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- SEC Form 4 filed by Jerman Michael Allen4 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- SEC Form 3 filed by new insider Shekhat Denil Nanji3 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- SEC Form 3 filed by new insider Del Giudice Matthew Paul3 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)
- SEC Form 3 filed by new insider Macpherson Edward Clouston3 - MIRA PHARMACEUTICALS, INC. (0001904286) (Issuer)